Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulm

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Zeitschrift Fur Kardiologie|March 1, 1986
[New statistical criteria for validation of the antiarrhythmic effects by acute oral testing]G Schmidt, K Ulm, L Goedel-Meinen, et al.
Anticancer Research|August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin LC Thomssen, P Oppelt, F Jänicke, et al.
International Archives of Occupational and Environmental Health|January 1, 1995
Carbon disulphide. III. Risk factors for coronary heart diseases in workers in the viscose industryH Drexler, K Ulm, M Hubmann, et al.
Breast Cancer Research and Treatment|July 29, 1999
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapseN Harbeck, C Thomssen, U Berger, et al.
Cancer|December 18, 2001
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinomaW Kuhn, S Rutke, K Späthe, et al.
Klinische Wochenschrift|August 1, 1982
Protein synthesis in the blood lymphocytes of chronic lymphocytic leukemia and its relationship to prognosisB Emmerich, R Pichlmeier, R Ristione, et al.
Pacing and Clinical Electrophysiology : PACE|June 1, 1996
Variability of ventricular premature complexes and mortality riskG Schmidt, G E Morfill, P Barthel, et al.
International Journal of Oncology|March 24, 1999
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancerN Harbeck, J S Ross, S Yurdseven, et al.
Zeitschrift Fur Kardiologie|February 1, 1988
[Spontaneous variability of complex ventricular extrasystoles over a period of up to 4 years]G Schmidt, K Ulm, L Goedel-Meinen, et al.
Thrombosis and Haemostasis|July 1, 1997
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapyM Schmitt, N Harbeck, C Thomssen, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Zeitschrift Fur Kardiologie|March 1, 1986
[New statistical criteria for validation of the antiarrhythmic effects by acute oral testing]G Schmidt, K Ulm, L Goedel-Meinen, et al.
Anticancer Research|August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin LC Thomssen, P Oppelt, F Jänicke, et al.
International Archives of Occupational and Environmental Health|January 1, 1995
Carbon disulphide. III. Risk factors for coronary heart diseases in workers in the viscose industryH Drexler, K Ulm, M Hubmann, et al.
Breast Cancer Research and Treatment|July 29, 1999
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapseN Harbeck, C Thomssen, U Berger, et al.
Cancer|December 18, 2001
Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinomaW Kuhn, S Rutke, K Späthe, et al.
Klinische Wochenschrift|August 1, 1982
Protein synthesis in the blood lymphocytes of chronic lymphocytic leukemia and its relationship to prognosisB Emmerich, R Pichlmeier, R Ristione, et al.
Pacing and Clinical Electrophysiology : PACE|June 1, 1996
Variability of ventricular premature complexes and mortality riskG Schmidt, G E Morfill, P Barthel, et al.
International Journal of Oncology|March 24, 1999
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancerN Harbeck, J S Ross, S Yurdseven, et al.
Zeitschrift Fur Kardiologie|February 1, 1988
[Spontaneous variability of complex ventricular extrasystoles over a period of up to 4 years]G Schmidt, K Ulm, L Goedel-Meinen, et al.
Thrombosis and Haemostasis|July 1, 1997
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapyM Schmitt, N Harbeck, C Thomssen, et al.
Pageof 13